Literature DB >> 18819676

Global change: impact, management, risk approach and health measures--the case of Europe.

B Dufour1, F Moutou, A M Hattenberger, F Rodhain.   

Abstract

Global changes, including an increase in trade and global warming, which act on the environment, are likely to impact on the evolution of pathogens and hence of diseases. To anticipate the risks created by this new situation, a French group of experts has developed a method for prioritising animal health risks. This is a two-phase method: the first step is to identify the diseases whose incidence or geographical distribution could be affected by the changes taking place, and the second step is to evaluate the risk of each of these diseases. As a result of this process, six priority diseases were selected: bluetongue, Rift Valley fever, West Nile fever, visceral leishmaniasis, leptospirosis and African horse sickness. The main recommendations were: to develop epidemiological surveillance, to increase knowledge of epidemiological cycles, to develop research into these diseases and to pool cross-border efforts to control them.

Entities:  

Mesh:

Year:  2008        PMID: 18819676

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  19 in total

1.  Comparison of real-time PCR assays for detection of pathogenic Leptospira spp. in blood and identification of variations in target sequences.

Authors:  Pascale Bourhy; Sylvie Bremont; Farida Zinini; Claude Giry; Mathieu Picardeau
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 2.  Virulence of the zoonotic agent of leptospirosis: still terra incognita?

Authors:  Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2017-03-06       Impact factor: 60.633

3.  Molecular and serological characterization of Leptospira interrogans serovar Canicola isolated from dogs, swine, and bovine in Brazil.

Authors:  Fabiana Miraglia; Zenaide M de Morais; Odir A Dellagostin; Fabiana K Seixas; Julio C Freitas; Francielle G S Zacarias; Adina C Delbem; Thaís S P Ferreira; Gisele O Souza; Rudy A Hartskeerl; Silvio A Vasconcellos; Andrea M Moreno
Journal:  Trop Anim Health Prod       Date:  2012-05-20       Impact factor: 1.559

4.  A field-study on Leptospira seroprevalence in dairy cows in four geographical areas in Sweden.

Authors:  Elisabeth Lindahl; Sofia Boqvist; Karin Artursson; Ulf Magnusson
Journal:  Acta Vet Scand       Date:  2011-10-12       Impact factor: 1.695

Review 5.  Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases.

Authors:  N James Maclachlan; Alan J Guthrie
Journal:  Vet Res       Date:  2010-01-27       Impact factor: 3.683

6.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

7.  Simulating spread of Bluetongue Virus by flying vectors between hosts on pasture.

Authors:  Kaare Graesbøll; René Bødker; Claes Enøe; Lasse E Christiansen
Journal:  Sci Rep       Date:  2012-11-16       Impact factor: 4.379

Review 8.  A survey of the transmission of infectious diseases/infections between wild and domestic ungulates in Europe.

Authors:  Claire Martin; Paul-Pierre Pastoret; Bernard Brochier; Marie-France Humblet; Claude Saegerman
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

9.  Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA.

Authors:  Brian T Backstedt; Ozlem Buyuktanir; Janet Lindow; Elsio A Wunder; Mitermayer G Reis; Sahar Usmani-Brown; Michel Ledizet; Albert Ko; Utpal Pal
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

10.  A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.

Authors:  Nadia Oreshkova; Lucien van Keulen; Jet Kant; Rob J M Moormann; Jeroen Kortekaas
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.